These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 12384161)

  • 1. Similar age-specific PSA, complexed PSA, and percent cPSA levels among African-American and white men of southern Louisiana. Prostate-specific antigen.
    Martin B; Cheli C; Pollard S; Sullivan J; Goodman J; Kokatnur M; Ward M; Martin L; Mercante D; Rayford W
    Urology; 2003 Feb; 61(2):375-9. PubMed ID: 12597951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total, free, and complexed prostate-specific antigen levels among US men, 2007-2010.
    Lacher DA; Hughes JP
    Clin Chim Acta; 2015 Aug; 448():220-7. PubMed ID: 26093340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Exploration and validation of optimal cut-off values for tPSA and fPSA/tPSA screening of prostate cancer at different ages].
    Liu XM; Duan HY; Zhang DQ; Chen C; Ji YT; Zhang YM; Feng ZW; Liu Y; Li JJ; Zhang Y; Li CY; Zhang YC; Yang L; Lyu ZY; Song FF; Song FJ; Huang YB
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):354-364. PubMed ID: 38644271
    [No Abstract]   [Full Text] [Related]  

  • 4. Associations of serum vitamin A and carotenoid levels with markers of prostate cancer detection among US men.
    Beydoun HA; Shroff MR; Mohan R; Beydoun MA
    Cancer Causes Control; 2011 Nov; 22(11):1483-95. PubMed ID: 21800039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study on percent free prostate specific antigen as an additional tool in prostate cancer screening.
    Omar J; Jaafar Z; Abdullah MR
    Malays J Med Sci; 2009 Jan; 16(1):44-7. PubMed ID: 22589648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of the diagnostic accuracy of prostate specific antigen.
    Harvey P; Basuita A; Endersby D; Curtis B; Iacovidou A; Walker M
    BMC Urol; 2009 Sep; 9():14. PubMed ID: 19744336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Exploration of the Value of Combined UA, IL-6, and fPSA/tPSA in the Diagnosis of Prostate Cancer.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9839167. PubMed ID: 38094390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.
    Roddam AW; Duffy MJ; Hamdy FC; Ward AM; Patnick J; Price CP; Rimmer J; Sturgeon C; White P; Allen NE;
    Eur Urol; 2005 Sep; 48(3):386-99; discussion 398-9. PubMed ID: 15982797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: systematic review and meta-analysis.
    Bruzzese D; Mazzarella C; Ferro M; Perdonà S; Chiodini P; Perruolo G; Terracciano D
    Transl Res; 2014 Dec; 164(6):444-51. PubMed ID: 25035153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?
    Naya Y; Stamey TA; Cheli CD; Partin AW; Sokoll LJ; Chan DW; Brawer MK; Taneja SS; Lepor H; Bartsch G; Childs S; Fritsche HA; Babaian RJ
    Urology; 2002 Oct; 60(4 Suppl 1):36-41. PubMed ID: 12384161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
    Djavan B; Remzi M; Zlotta AR; Ravery V; Hammerer P; Reissigl A; Dobronski P; Kaisary A; Marberger M
    Urology; 2002 Oct; 60(4 Suppl 1):4-9. PubMed ID: 12384156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL.
    Okegawa T; Kinjo M; Ohta M; Miura I; Horie S; Nutahara K; Higashihara E
    Int J Urol; 2003 Apr; 10(4):201-6. PubMed ID: 12657099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.
    Naya Y; Fritsche HA; Cheli CD; Stamey TA; Bartsch G; Brawer MK; Childs S; Taneja SS; Lepor H; Partin AW; Sokoll LJ; Chan DW; Babaian RJ
    Urology; 2003 Dec; 62(6):1058-62. PubMed ID: 14665355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL.
    Okegawa T; Kinjo M; Watanabe K; Noda H; Kato M; Miyata A; Murata A; Yoshii M; Nutahara K; Higashihara E
    BJU Int; 2000 Apr; 85(6):708-14. PubMed ID: 10759671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer.
    Okegawa T; Noda H; Nutahara K; Higashihara E
    Eur Urol; 2000 Oct; 38(4):380-7. PubMed ID: 11025374
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.